Ocelot Bio
About:
Ocelot Bio brings new treatment options to patients with severe liver disease.
Website: http://www.ocelotbio.com/
Twitter/X: OcelotBio
Top Investors: RA Capital Management, Vivo Capital, Venrock
Description:
Ocelot Bio brings new treatment options to patients with severe liver disease. It researches and discovers medicines that help in the treatment of hepatorenal syndrome, a complication of severe liver disease.
Total Funding Amount:
$39M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2020-01-01
Founders:
Gebhard Neyer, Geoff Harris
Number of Employees:
11-50
Last Funding Date:
2023-07-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai